Papillary and follicular thyroid carcinomas are among the most curable of a
ll cancers. However, some patients are at high risk of recurrence or even d
eath from their cancer. Most of these patients can be identified at the tim
e of diagnosis using well-established prognostic indicators. The extent of
initial treatment and follow-up should therefore be individualized. The ear
ly discovery of persistent and recurrent disease is based on the combined u
se of serum thyroglobulin determination and of total body scanning with I-1
31. The recent availability of recombinant human thyroid stimulating hormon
e has greatly improved the quality of the patient's life during follow-up.
Treatment of recurrences is based mainly on surgery and I-131 treatment.